News

ConocoPhillips Canada Resources Corp. was registered this past week by Alicia Adams, a consultant with Earnscliffe Strategy ...
Modella AI has signed a multi-year agreement with AstraZeneca for expediting AI-driven oncology clinical development.
Antibody-Drug Conjugates (ADC) Market- Driven by Advanced Payload Technologies and Strategic Industry Partnerships Sai Kumar DataM Intelligence 4market Research LLP +1 877-441-4866 ... Visit us on ...
The company is betting that the alternative cytotoxic payload in its ADC can overcome resistance in patients who relapse on Enhertu.
New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...
During a live event, Heather L. McArthur, MD, MPH, discussed the TAILORx trial in node-negative hormone ...
Just days after President Donald Trump was elected in November, AstraZeneca unvei | AstraZeneca CEO Pascal Soriot is plotting ...
Industry veteran Catherine Owen Adams expects external innovation will be key to getting the brain-focused drug developer to “the next level.” ...
Datroway is used to treat an advanced form of non-small cell lung cancer in adults who had received prior treatment.
Rise in geriatric population; increase in healthcare expenditure; and increase in investments in R&D activities by various healthcare companies.” — Allied Market Research PORTLAND, IN, UNITED STATES, ...
AstraZeneca chief executive Pascal Soriot is considering moving the company's stock exchange listing from the UK to the US – ...
The Contrast Media Market is projected to grow at a CAGR of 5-6%. Key factors influencing the contrast media market include ...